SEARCH

SEARCH BY CITATION

References

  • Amaral D. G., Bauman M. D., Capitanio J. P., Lavenex P., Mason W. A., Mauldin-Jourdain M. L. and Mendoza S. P. (2003) The amygdala: is it an essential component of the neural network for social cognition? Neuropsychologia 41, 517522.
  • Arvin M., Fedorkova L., Disshon K. A., Dluzen D. E. and Leipheimer R. E. (2000) Estrogen modulates responses of striatal dopamine neurons to MPP(+): evaluations using in vitro and in vivo techniques. Brain Res. 872, 160171.
  • Bazzett T. J. and Becker J. B. (1994) Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding. Brain Res. 637, 163172.
  • Blanchard V., Anglade P., Dziewczapolski G., Savasta M., Agid Y. and Raisman-Vozari R. (1996) Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra. Brain Res. 709, 319325.
  • Bower J. H., Maraganore D. M., McDonnell S. K. and Rocca W. A. (1999) Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–90. Neurology 52, 12141220.
  • Braak H. and Braak E. (2000) Pathoanatomy of Parkinson's disease. J. Neurol. 247, II310.
  • Braak H., Braak E., Yilmazer D., De Vos R. A., Jansen E. N., Bohl J. and Jellinger K. (1994) Amygdala pathology in Parkinson's disease. Acta Neuropathol. (Berl.) 88, 493500.
  • Chinaglia G., Alvarez F. J., Probst A. and Palacios J. M. (1992) Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Neuroscience 49, 317327.
  • Deumens R., Blokland A. and Prickaerts J. (2002) Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 175, 303317.
  • Diamond S. G., Markham C. H., Hoehn M. M., McDowell F. H. and Muenter M. D. (1990) An examination of male-female differences in progression and mortality of Parkinson's disease. Neurology 40, 763766.
  • Dluzen D. (1997) Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res. 767, 340344.
  • Dluzen D. E. (2000) Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system. J. Neurocytol. 29, 387399.
  • Fernandez-Ruiz J. J., Amor J. C. and Ramos J. A. (1989) Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors. Brain Res. 476, 388395.
  • Ferraz A. C., Xavier L. L., Hernandes S., Sulzbach M., Viola G. G., Anselmo-Franci J. A., Achaval M. and Da Cunha C. (2003) Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine. Brain Res. 986, 200205.
  • Hruska R. E. (1986) Elevation of striatal dopamine receptors by estrogen: dose and time studies. J. Neurochem. 47, 19081915.
  • Kalivas P. W. (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Brain Res. Rev. 18, 75113.
  • Liu B. and Xie J. X. (2001) Recent progresses on the modulation of estrogen to dopaminergic neurons. Sheng Li Ke Xue Jin Zhan 32, 259261.
  • Liu B. and Xie J. X. (2002) Estrogen actions on dopamine release from the amygdala and behavioral changes in a Parkinson's disease model rat. Acta Acad. Med. Qingdao Uni. 38, 111113.
  • Liu B., Dong X. L., Xie J. X., Gou Y. L., Rowlands D. K. and Chan H. C. (2003) Effect of Bak Foong pills on enhancing dopamine release from the amygdala of female rats. Biol. Pharm. Bull. 26, 10281030.
  • Murray H. E., Pillai A. V., McArthur S. R., Razvi N., Datla K. P., Dexter D. T. and Gillies G. E. (2003) Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. Neuroscience 116, 213222.
  • Ouchi Y., Yoshikawa E., Okada H., Futatsubashi M., Sekine Y., Iyo M. and Sakamoto M. (1999) Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann. Neurol. 45, 601610.
  • Reid I. R. (2002) Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety. Expert Opin. Drug Saf. 1, 93107.
  • Saunders-Pullman R., Gordon-Elliott J., Parides M., Fahn S., Saunders H. R. and Bressman S. (1999) The effect of estrogen replacement on early Parkinson's disease. Neurology 52, 14171421.
  • Schmitz Y., Schmauss C. and Sulzer D. (2002) Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J. Neurosci. 22, 80028009.
  • Shimizu H. and Bray G. A. (1993) Effects of castration, estrogen replacement and estrus cycle on monoamine metabolism in the nucleus accumbens, measured by microdialysis. Brain Res. 621, 200206.
  • Stamford J. A. (1990) Fast cyclic voltammetry: measuring transmitter release in ‘real time’. J. Neurosci. Meth. 34, 6772.
  • Tessitore A., Hariri A. R., Fera F., Smith W. G., Chase T. N., Hyde T. M., Weinberger D. R. and Mattay V. S. (2002) Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J. Neurosci. 22, 90999103.
  • Thompson T. L. and Moss R. L. (1997) Modulation of mesolimbic dopaminergic activity over the rat estrous cycle. Neurosci. Lett. 229, 145148.
  • Xie J. X., Tang M., Ocertel W. H. and Earl C. D. (1997) Sex differences in amygdaloid dopamine release following electrical stimulation of the ventral tegmental area: an in vivo voltammetric study. Chin. J. Physiol. Sci. 13, 1724.
  • Zhou Y., Zhao Z. Q. and Xie J. X. (2001) Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats. Brain Res. 917, 127132.